Safety and Discontinuation Rate of Dimethyl Fumarate (Zadiva ® ) in Patients with Multiple Sclerosis: An Observational Retrospective Study.
Roya AbolfazliMohammad Ali SahraianAtefeh TayebiHamidreza KafiSara SamadzadehPublished in: Journal of clinical medicine (2023)
is an effective and safe treatment option for RRMS patients in real-world practice.